Improving diagnosis and outcomes for primary progressive aphasia
Toward Personalized Prognosis and Outcomes in Primary Progressive Aphasia
This study is looking at ways to better understand and diagnose primary progressive aphasia (PPA), a condition that affects how people communicate, by using advanced brain imaging techniques, so that doctors can provide better care and support for those living with PPA.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10634041 on NIH RePORTER |
What this research studies
This research focuses on primary progressive aphasia (PPA), a neurodegenerative condition that primarily affects language abilities while sparing other cognitive functions in its early stages. The team aims to develop advanced imaging techniques, including tau and amyloid imaging, to differentiate between the various subtypes of PPA and their underlying causes. By utilizing functional connectivity MRI and other imaging methods, the research seeks to provide more accurate diagnoses and better prognostic tools for monitoring disease progression and treatment effects. This could lead to improved clinical practices for healthcare providers treating patients with PPA.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with primary progressive aphasia or those exhibiting early symptoms of this condition.
Not a fit: Patients with other forms of dementia or cognitive disorders unrelated to primary progressive aphasia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of primary progressive aphasia, ultimately improving patient management and treatment outcomes.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for diagnosing neurodegenerative diseases, suggesting that this approach could be effective for PPA as well.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Dickerson, Bradford C — Massachusetts General Hospital
- Study coordinator: Dickerson, Bradford C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.